重點成果

重點成果

• 
  2021-07-13 重點成果

  Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function

  黃雯華
  Scientific Reports

• 
  2021-06-01 重點成果

  SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection

  謝世良
  The Journal of Clinical Investigation

• 
  2021-05-25 重點成果

  Activation of Prp28 ATPase by Phosphorylated Npl3 at a Critical Step of Spliceosome Remodeling

  張典顯
  Nature Communications

• 
  2021-05-10 重點成果

  Marginal Zone B Cells Assist With Neutrophil Accumulation to Fight Against Systemic Staphylococcus aureus Infection

  林國儀
  FRONTIERS IN IMMUNOLOGY

• 
  2021-04-14 重點成果

  HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma

  楊懷壹
  The Journal of Infectious Diseases

• 
  2021-03-26 重點成果

  Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodies

  吳宗益
  Bioorganic Chemistry

• 
  2021-03-03 重點成果

  Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer

  李文華
  Science Translational Medicine

• 
  2021-03-03 重點成果

  Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation via Reduction of Reactive Oxygen Species Production and Lysosomal Rupture

  謝世良
  Frontiers in immunology

• 
  2021-03-03 重點成果

  Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation

  楊懷壹
  Clinical Gastroenterology and Hepatology

• 
  2021-02-26 重點成果

  Practical Remdesivir Synthesis through One-Pot Organo-Catalyzed Asymmetric (S)-P-Phosphoramidation

  洪上程, 翁啟惠
  JOC